Orchid Pharma Q1 Results
- BSE: 524372
- NSE: ORCHPHARMA
- ISIN: INE191A01027
- Sector: Biotechnology & Drugs
BSE
1,020.05
-13.95 (-1.35%)
-13.95 (-1.35%)Volume4.03 K
Updated: Thu 18 Jun, 2026 | 13:18:36
NSE
1,018.65-18.20 (-1.76%)
-18.20 (-1.76%)Volume50.77 K
Updated: Thu 18 Jun, 2026 | 13:04:51
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q1 Results Highlights
Quarter ended Jun 25
Note: Comparison is on QoQ basis
Quarterly - Orchid Pharma Q1 Results
*All figures in crores except per share values
| Fiscal Period | Jun 25 | Mar 26 | QoQ Comp | Jun 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 167.41 | 219.07 | -23.34% | 220.36 | -24.03% |
| Depreciation/ Amortization | 8.65 | 8.87 | -2.45% | 8.44 | 2.49% |
| Operating Income | 5.52 | 18.54 | -71.11% | 24.05 | -77.04% |
| Net Income | 14.91 | 23.78 | -33.12% | 29.35 | -49.20% |
| Other Operating Expenses Total | 38.28 | 38.51 | -22.26% | 39.66 | -3.49% |
| Net Income Before Taxes | 13.71 | 22.79 | -28.19% | 28.12 | -51.24% |
| Total Revenue | 172.93 | 237.61 | -27.18% | 244.41 | -29.25% |
| Selling/ General/ Admin Expenses Total | 21.61 | 20.88 | -2.83% | 22.00 | -1.76% |
| Diluted Normalized EPS | 2.94 | 4.52 | -33.16% | 5.79 | -49.22% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.